Global Multiplex Biomarker Imaging Market Size Study, by Component Type, by Imaging Technique, by Application, by End User and Regional Forecasts 2022-2032

Description

Global Multiplex Biomarker Imaging Market is valued at approximately USD 532.8 million in 2023 and is anticipated to grow with a healthy growth rate of more than 10.86% over the forecast period 2024-2032. Multiplex biomarker imaging is an advanced technique that allows simultaneous visualization of multiple biomarkers within a single tissue sample. By using different fluorescent or chemical labels, this method can identify and quantify various proteins, nucleic acids, or other molecules of interest, providing comprehensive spatial and molecular information. It is particularly valuable in research and clinical diagnostics for understanding complex biological processes, such as cancer, immune responses, and tissue heterogeneity, by revealing the intricate interactions between different cellular components in their native environment.

The Global Multiplex Biomarker Imaging Market is driven by growing focus on personalized medicine mandates advanced imaging tools to customize therapies to individual patient profiles. Increased investment in biomedical research and healthcare infrastructure, along with strategic collaborations and partnerships, are expected to drive industry growth by fostering innovation and broadening application areas. In addition, technological advancements in high throughput imaging systems have revolutionized the simultaneous study of multiple biomarkers with exceptional precision, thereby enhancing diagnostic accuracy and efficiency. The rising prevalence of complex diseases such as cancer and neurological disorders necessitates extensive biomarker analysis, which is crucial for developing targeted therapeutics. However, high cost of imaging systems is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the largest region in the multiplex biomarker imaging market driven by an upsurge in clinical research on chronic diseases and various cancer types in the region. The Asia-Pacific region is anticipated to be the fastest-growing during the forecast period, fueled by rapid advancements in healthcare infrastructure and increasing research activities.

Major market players included in this report are:

PerkinElmer Inc.
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Abcam plc.
Merck KGaA
Illumina Inc.
Leica BiosystemsNussloch GmbH
Ventana Medical Systems, Inc.
AushonBioSystems Ltd.
MicroConstants, Inc.
ToposNomos Ltd.
Agilent Technologies, Inc.

The detailed segments and sub-segment of the market are explained below:

By Component Type:

Instruments
Software
Services

By Imaging Technique:

Immunohistochemistry (IHC) Assay
Fluorescent in Situ Hybridization (FISH) Assay
Tissue Microarray (TMA) Assay

By Application:

Research
Clinical Diagnostics

By End User:

Translation Laboratories
Biopharmaceutical Companies
Academic Institutes

By Region:

North America:

U.S.
Canada

Europe:

UK
Germany
France
Spain
Italy
ROE

Asia Pacific:

China
India
Japan
Australia
South Korea
RoAPAC

Latin America:

Brazil
Mexico
RoLA

Middle East & Africa:

Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

Chapter 1. Global Multiplex Biomarker Imaging Market Executive Summary

1.1. Global Multiplex Biomarker Imaging Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Component Type
- 1.3.2. By Imaging Technique
- 1.3.3. By Application
- 1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Multiplex Biomarker Imaging Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Multiplex Biomarker Imaging Market Dynamics

3.1. Market Drivers
- 3.1.1. Technological Advancements in Imaging Systems
- 3.1.2. Rising Prevalence of Complex Diseases
- 3.1.3. Increased Emphasis on Personalized Medicine
3.2. Market Challenges
- 3.2.1. High Cost of Imaging Systems
- 3.2.2. Regulatory and Compliance Issues
3.3. Market Opportunities
- 3.3.1. Growing Investment in Biomedical Research
- 3.3.2. Expansion of Application Areas

Chapter 4. Global Multiplex Biomarker Imaging Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Multiplex Biomarker Imaging Market Size & Forecasts by Component Type 2022-2032

5.1. Segment Dashboard
5.2. Global Multiplex Biomarker Imaging Market: Component Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 5.2.1. Instruments
- 5.2.2. Software
- 5.2.3. Services

Chapter 6. Global Multiplex Biomarker Imaging Market Size & Forecasts by Imaging Technique 2022-2032

6.1. Segment Dashboard
6.2. Global Multiplex Biomarker Imaging Market: Imaging Technique Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 6.2.1. Immunohistochemistry (IHC) Assay
- 6.2.2. Fluorescent in Situ Hybridization (FISH) Assay
- 6.2.3. Tissue Microarray (TMA) Assay

Chapter 7. Global Multiplex Biomarker Imaging Market Size & Forecasts by Application 2022-2032

7.1. Segment Dashboard
7.2. Global Multiplex Biomarker Imaging Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 7.2.1. Research
- 7.2.2. Clinical Diagnostics

Chapter 8. Global Multiplex Biomarker Imaging Market Size & Forecasts by End User 2022-2032

8.1. Segment Dashboard
8.2. Global Multiplex Biomarker Imaging Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 8.2.1. Translational Laboratories
- 8.2.2. Biopharmaceutical Companies
- 8.2.3. Academic Institutes

Chapter 9. Global Multiplex Biomarker Imaging Market Size & Forecasts by Region 2022-2032

9.1. North America Multiplex Biomarker Imaging Market
- 9.1.1. U.S. Multiplex Biomarker Imaging Market
  - 9.1.1.1. Component Type breakdown size & forecasts, 2022-2032
  - 9.1.1.2. Imaging Technique breakdown size & forecasts, 2022-2032
  - 9.1.1.3. Application breakdown size & forecasts, 2022-2032
  - 9.1.1.4. End User breakdown size & forecasts, 2022-2032
- 9.1.2. Canada Multiplex Biomarker Imaging Market
9.2. Europe Multiplex Biomarker Imaging Market
- 9.2.1. UK Multiplex Biomarker Imaging Market
- 9.2.2. Germany Multiplex Biomarker Imaging Market
- 9.2.3. France Multiplex Biomarker Imaging Market
- 9.2.4. Spain Multiplex Biomarker Imaging Market
- 9.2.5. Italy Multiplex Biomarker Imaging Market
- 9.2.6. Rest of Europe Multiplex Biomarker Imaging Market
9.3. Asia-Pacific Multiplex Biomarker Imaging Market
- 9.3.1. China Multiplex Biomarker Imaging Market
- 9.3.2. India Multiplex Biomarker Imaging Market
- 9.3.3. Japan Multiplex Biomarker Imaging Market
- 9.3.4. Australia Multiplex Biomarker Imaging Market
- 9.3.5. South Korea Multiplex Biomarker Imaging Market
- 9.3.6. Rest of Asia Pacific Multiplex Biomarker Imaging Market
9.4. Latin America Multiplex Biomarker Imaging Market
- 9.4.1. Brazil Multiplex Biomarker Imaging Market
- 9.4.2. Mexico Multiplex Biomarker Imaging Market
- 9.4.3. Rest of Latin America Multiplex Biomarker Imaging Market
9.5. Middle East & Africa Multiplex Biomarker Imaging Market
- 9.5.1. Saudi Arabia Multiplex Biomarker Imaging Market
- 9.5.2. South Africa Multiplex Biomarker Imaging Market
- 9.5.3. Rest of Middle East & Africa Multiplex Biomarker Imaging Market

Chapter 10. Competitive Intelligence

10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
- 10.3.1. PerkinElmer Inc.
  - 10.3.1.1. Key Information
  - 10.3.1.2. Overview
  - 10.3.1.3. Financial (Subject to Data Availability)
  - 10.3.1.4. Product Summary
  - 10.3.1.5. Market Strategies
- 10.3.2. Thermo Fisher Scientific, Inc.
- 10.3.3. Bio-Rad Laboratories, Inc.
- 10.3.4. Abcam plc.
- 10.3.5. Merck KGaA
- 10.3.6. Illumina Inc.
- 10.3.7. Leica Biosystems Nussloch GmbH
- 10.3.8. Ventana Medical Systems, Inc.
- 10.3.9. Aushon BioSystems Ltd.
- 10.3.10. MicroConstants, Inc.
- 10.3.11. ToposNomos Ltd.
- 10.3.12. Agilent Technologies, Inc.

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes